Treatment of Inflammatory Bowel Disease with Biologics
319 https://www.ecco-ibd.eu), and reputable Internet sites. Although patients can get reliable and easily understandable informa ...
320 previous TB infection or having undergone previous treatment for active TB or latent TB infection [ 24 ]. There are no 100% ...
321 With regard to tuberculosis, active TB has infrequently occurred in vedolizumab- exposed patients, and all cases occurred in ...
322 anti-TNF treatment is planned [ 37 ]. In addition, HPV vaccination in women and men ≤26 years should be considered, due to i ...
323 Annual tuberculosis screening during maintenance therapy with anti-TNF agents should be performed among patients at high ris ...
324 Select Patient Populations: The Elderly Approximately 15% of IBD cases are diagnosed after 65 years of age, and with the agi ...
325 to discontinue biologic therapy should therefore be individualized, taking into account disease phenotypes, preceding diseas ...
326 Dryden GW. Optimizing the use of biologic therapies in the management of inflammatory bowel disease. Gastroenterol Hepatol ...
327 Melmed GY, Targan SR. In: Podolsky DK, Camilleri M, Fitz JG, Kalloo AN, Shanahan F, Wang TC, editors. Crohn’s disease: cli ...
328 Lobaton T, et al. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Phar ...
© Springer International Publishing AG 2018 329 A.S. Cheifetz, J.D. Feuerstein (eds.), Treatment of Inflammatory Bowel Disease w ...
330 Anti-tumor necrosis factor (anti-TNF) agents (cont.) patient education, 28–30 patient preference, 29 pediatric IBD, 42 perio ...
331 hepatotoxicity, 231 infliximab, 316 infusion/injection site reactions, 231 leukocyte trafficking inhibition, 114 lupus-like ...
332 D Delaying surgery, 132 Demyelinating disease, 249, 251, 253 Drug and antidrug antibody assays, 316 E Eczematiform lesions c ...
333 Infectious complications, 187–193, 202 and biologic therapy, 186 adalimumab, 189 anti-integrin antibodies, 190 certolizumab, ...
334 Pediatric Crohn’s disease (cont.) dose optimization, 165 endoscopic lesion severity scores, 164 immunomodulatory therapy, 16 ...
335 Psoriasiform eruptions clinical presentation, 236, 237 diagnosis, 241 genetic pathways, 240 management, 242, 243 paradoxical ...
«
8
9
10
11
12
13
14
15
16
17
»
Free download pdf